Kaposi's Sarcoma After Autologous Stem-Cell Transplantation and Rituximab Treatment

J Oncol Pract. 2018 Sep;14(9):565-568. doi: 10.1200/JOP.18.00246. Epub 2018 Jul 25.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antineoplastic Agents, Immunological / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cisplatin / therapeutic use
  • Cytarabine / therapeutic use
  • Dexamethasone / therapeutic use
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lymphoma, Mantle-Cell / therapy*
  • Male
  • Middle Aged
  • Oxaliplatin / therapeutic use
  • Rituximab / therapeutic use*
  • Sarcoma, Kaposi / etiology*
  • Transplantation, Autologous

Substances

  • Antineoplastic Agents, Immunological
  • Immunosuppressive Agents
  • Cytarabine
  • Oxaliplatin
  • Rituximab
  • Dexamethasone
  • Cisplatin